Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$16.95 - $27.04 $857,059 - $1.37 Million
50,564 New
50,564 $1.37 Million
Q3 2023

Nov 13, 2023

SELL
$14.99 - $32.65 $3.67 Million - $8 Million
-245,029 Reduced 85.61%
41,195 $617,000
Q1 2023

May 15, 2023

SELL
$38.09 - $57.79 $343,762 - $521,554
-9,025 Reduced 3.06%
286,224 $11.2 Million
Q4 2022

Feb 14, 2023

BUY
$40.54 - $56.2 $874,731 - $1.21 Million
21,577 Added 7.88%
295,249 $15.6 Million
Q3 2022

Nov 14, 2022

SELL
$36.98 - $49.2 $1.25 Million - $1.67 Million
-33,916 Reduced 11.03%
273,672 $12.3 Million
Q2 2022

Aug 12, 2022

SELL
$28.03 - $45.8 $56,116 - $91,691
-2,002 Reduced 0.65%
307,588 $11.2 Million
Q1 2022

May 16, 2022

BUY
$29.24 - $44.06 $773,661 - $1.17 Million
26,459 Added 9.35%
309,590 $12.8 Million
Q4 2021

Feb 14, 2022

SELL
$39.32 - $61.61 $84,931 - $133,077
-2,160 Reduced 0.76%
283,131 $12.1 Million
Q3 2021

Nov 15, 2021

SELL
$44.0 - $65.8 $195,404 - $292,217
-4,441 Reduced 1.53%
285,291 $15.7 Million
Q2 2021

Aug 16, 2021

SELL
$44.66 - $63.06 $623,319 - $880,128
-13,957 Reduced 4.6%
289,732 $13.9 Million
Q1 2021

May 14, 2021

SELL
$46.31 - $62.7 $107,022 - $144,899
-2,311 Reduced 0.76%
303,689 $15.4 Million
Q4 2020

Mar 01, 2021

SELL
$55.51 - $69.94 $497,536 - $626,872
-8,963 Reduced 2.85%
306,000 $19.3 Million
Q3 2020

Nov 13, 2020

BUY
$42.19 - $69.61 $12.4 Million - $20.4 Million
293,163 Added 1344.78%
314,963 $21.2 Million
Q2 2020

Aug 14, 2020

BUY
$27.55 - $43.28 $421,515 - $662,184
15,300 Added 235.38%
21,800 $913,000
Q1 2020

May 15, 2020

BUY
$23.16 - $47.8 $13,896 - $28,680
600 Added 10.17%
6,500 $204,000
Q4 2019

Feb 14, 2020

BUY
$27.97 - $40.38 $165,023 - $238,242
5,900 New
5,900 $238,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.